Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.

Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, Fearon DT.

Proc Natl Acad Sci U S A. 1984 Jul;81(14):4510-4.

3.

Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.

Hutt-Fletcher LM, Fowler E, Lambris JD, Feighny RJ, Simmons JG, Ross GD.

J Immunol. 1983 Mar;130(3):1309-12.

PMID:
6218205
4.

Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.

Weis JJ, Tedder TF, Fearon DT.

Proc Natl Acad Sci U S A. 1984 Feb;81(3):881-5.

5.

Biochemical and antigenic analysis of the Epstein Barr virus/C3d receptor (CR2).

Siaw MF, Nemerow GR, Cooper NR.

J Immunol. 1986 Jun 1;136(11):4146-51.

PMID:
3009616
6.
8.
9.
11.
13.

Epstein-Barr virus receptor expression on human CD8+ (cytotoxic/suppressor) T lymphocytes.

Sauvageau G, Stocco R, Kasparian S, Menezes J.

J Gen Virol. 1990 Feb;71 ( Pt 2):379-86.

PMID:
2155291
15.

Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.

Delcayre AX, Salas F, Mathur S, Kovats K, Lotz M, Lernhardt W.

EMBO J. 1991 Apr;10(4):919-26.

16.

Quantification of C3dg/Epstein-Barr virus receptors on human B cells and B cell lines.

Rasmussen JM, Marquart HV, Rask R, Jepsen HH, Svehag SE.

Complement. 1988;5(2):98-107.

PMID:
2837360
17.

Expression of CR1 and CR2 complement receptors following Epstein-Barr virus infection of Burkitt's lymphoma cell lines.

Cohen JH, Fischer E, Kazatchkine MD, Lenoir GM, Lefevre-Delvincourt C, Revillard JP.

Scand J Immunol. 1987 Jun;25(6):587-98.

PMID:
3037684
18.

Characterization of the EBV/C3d receptor on the human Jurkat T cell line: evidence for a novel transcript.

Sinha SK, Todd SC, Hedrick JA, Speiser CL, Lambris JD, Tsoukas CD.

J Immunol. 1993 Jun 15;150(12):5311-20.

PMID:
8390533
19.

gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4).

Frade R, Myones BL, Barel M, Krikorian L, Charriaut C, Ross GD.

Eur J Immunol. 1985 Dec;15(12):1192-7.

PMID:
3878789
20.

Inhibition of Epstein-Barr virus infection in vitro and in vivo by soluble CR2 (CD21) containing two short consensus repeats.

Moore MD, Cannon MJ, Sewall A, Finlayson M, Okimoto M, Nemerow GR.

J Virol. 1991 Jul;65(7):3559-65.

Supplemental Content

Support Center